Keyphrases
Systemic Sclerosis
33%
Macrophages
20%
Biomarker Discovery
16%
Treatment Implications
16%
Population Focus
16%
Clinical Transcriptomics
16%
Early Disease
16%
Disease Process
16%
Fibrosis
16%
Biomarkers Treatment
16%
Drug Delivery System
16%
Cyclodextrin Nanosponges
16%
Glutathione-responsive
16%
Doxorubicin
16%
Hepatotoxicity
16%
Toxicity Evaluation
16%
Toxicity Mechanism
16%
Liver
16%
Transport Mechanism
16%
Efflux
11%
GSH Content
11%
Lung
10%
Inflammation
9%
Scar
6%
Vital Organs
5%
Monocytes
5%
Hepatic Accumulation
5%
Drug Pump
5%
Antitumoral Activity
5%
Free Drug
5%
GSH-responsive
5%
Nanosponges
5%
HepG2 Cells
5%
Organotypic Culture
5%
Medicaments
5%
Chemoresistant
5%
Anticancer Drugs
5%
Good Safety
5%
Rat Liver
5%
Precision-cut Liver Slices
5%
Drug Resistance Reversal
5%
Safety Profile
5%
Active Mechanism
5%
Immunology and Microbiology
Systemic Scleroderma
100%
Raynaud Phenomenon
30%
Glycation
22%
Fibroblast
20%
Macrophage
20%
interferon
18%
Chemokine
16%
Transcriptomics
16%
Monocyte
8%
Oxidative Stress
7%
Scar Formation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
66%
Interstitial Lung Disease
43%
Biological Marker
23%
Pulmonary Hypertension
20%
Disease
16%
Chemokine
16%
Advanced Glycation End Product Receptor
16%
Inflammation
8%
Fibrosis
7%
Scar Formation
6%
Mammalia
5%
